A previous study suggested no difference in the expression of activated CD8+CD38+ T cells between patients who developed malignancies and non-cancer patients (29), but in a Danish cohort of solid organ transplant recipients, older age and elevated levels of C-reactive protein, a circulating marker of inflammation, correlated with a high risk for cancer development (30). Here, CD38 is linked to cancer.